Nathalie L Momplaisir, Naincy R Chandan, Beiyun Wang, Elaine Qu, Alan V Smrcka
{"title":"GoLoco/GPR基序依赖的Gαo对Rap1GAP1的调控被Gαo脑病变体破坏。","authors":"Nathalie L Momplaisir, Naincy R Chandan, Beiyun Wang, Elaine Qu, Alan V Smrcka","doi":"10.1016/j.jbc.2025.110446","DOIUrl":null,"url":null,"abstract":"<p><p>G protein-coupled receptors (GPCRs) that couple to Gα<sub>i/o</sub> family members are major therapeutic targets. Among heterotrimeric G proteins, Gα<sub>o</sub> is the most abundant Gα subunit in the brain but the mechanistic pathways controlled by Gα<sub>o</sub> have not been thoroughly established. Understanding Gα<sub>o</sub>-mediated signalling pathways is especially critical given recent reports of a neurodevelopmental disorder (GNAO1 encephalopathy) associated with mutations in the Gα<sub>o</sub>-encoding gene. To address this gap, we sought to uncover novel Gα<sub>o</sub> effectors using a proximity-based proteomics screen in differentiated PC12 cells. Our analysis revealed a diverse set of potential Gα<sub>o</sub>-GTP effector proteins including a Rap1 GTPase activating protein, Rap1GAP1. Regulation of Rap1GAP1 by G protein α subunits is controversial, with Rap1GAP1 reported to bind preferentially to Gα<sub>o</sub>-GDP via a GoLoco/G protein regulatory (GPR) motif. We establish that Gα<sub>o</sub>-GTP binds and regulates Rap1GAP1 activity and reveal a novel mechanism for Gα subunit recognition by Rap1GAP1 where the presence or absence of key contact residues in the GoLoco/GPR motif confer differential recognition of Gα<sub>o</sub> guanine nucleotide binding status. We also show that pathologic GNAO1 mutations disrupt this functional relationship by preventing the activated Gα subunit from attaining a conformation required for effector binding. These data resolve controversies in the literature regarding activation-dependent binding and regulation of Rap1GAP by Gα<sub>o</sub> and help establish Rap1GAP1a as a bone fide G protein regulated effector. Furthermore, our study finds that multiple mutants in Gα<sub>o</sub> associated with GNAO1 encephalopathy have defects in downstream effector interactions, which could underly some of the manifestations of this disease.</p>","PeriodicalId":15140,"journal":{"name":"Journal of Biological Chemistry","volume":" ","pages":"110446"},"PeriodicalIF":4.0000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"GoLoco/GPR Motif-Dependent Regulation of Rap1GAP1 by Gα<sub>o</sub> is Disrupted by Gα<sub>o</sub> Encephalopathy Variants.\",\"authors\":\"Nathalie L Momplaisir, Naincy R Chandan, Beiyun Wang, Elaine Qu, Alan V Smrcka\",\"doi\":\"10.1016/j.jbc.2025.110446\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>G protein-coupled receptors (GPCRs) that couple to Gα<sub>i/o</sub> family members are major therapeutic targets. Among heterotrimeric G proteins, Gα<sub>o</sub> is the most abundant Gα subunit in the brain but the mechanistic pathways controlled by Gα<sub>o</sub> have not been thoroughly established. Understanding Gα<sub>o</sub>-mediated signalling pathways is especially critical given recent reports of a neurodevelopmental disorder (GNAO1 encephalopathy) associated with mutations in the Gα<sub>o</sub>-encoding gene. To address this gap, we sought to uncover novel Gα<sub>o</sub> effectors using a proximity-based proteomics screen in differentiated PC12 cells. Our analysis revealed a diverse set of potential Gα<sub>o</sub>-GTP effector proteins including a Rap1 GTPase activating protein, Rap1GAP1. Regulation of Rap1GAP1 by G protein α subunits is controversial, with Rap1GAP1 reported to bind preferentially to Gα<sub>o</sub>-GDP via a GoLoco/G protein regulatory (GPR) motif. We establish that Gα<sub>o</sub>-GTP binds and regulates Rap1GAP1 activity and reveal a novel mechanism for Gα subunit recognition by Rap1GAP1 where the presence or absence of key contact residues in the GoLoco/GPR motif confer differential recognition of Gα<sub>o</sub> guanine nucleotide binding status. We also show that pathologic GNAO1 mutations disrupt this functional relationship by preventing the activated Gα subunit from attaining a conformation required for effector binding. These data resolve controversies in the literature regarding activation-dependent binding and regulation of Rap1GAP by Gα<sub>o</sub> and help establish Rap1GAP1a as a bone fide G protein regulated effector. Furthermore, our study finds that multiple mutants in Gα<sub>o</sub> associated with GNAO1 encephalopathy have defects in downstream effector interactions, which could underly some of the manifestations of this disease.</p>\",\"PeriodicalId\":15140,\"journal\":{\"name\":\"Journal of Biological Chemistry\",\"volume\":\" \",\"pages\":\"110446\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Biological Chemistry\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jbc.2025.110446\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biological Chemistry","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.jbc.2025.110446","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
GoLoco/GPR Motif-Dependent Regulation of Rap1GAP1 by Gαo is Disrupted by Gαo Encephalopathy Variants.
G protein-coupled receptors (GPCRs) that couple to Gαi/o family members are major therapeutic targets. Among heterotrimeric G proteins, Gαo is the most abundant Gα subunit in the brain but the mechanistic pathways controlled by Gαo have not been thoroughly established. Understanding Gαo-mediated signalling pathways is especially critical given recent reports of a neurodevelopmental disorder (GNAO1 encephalopathy) associated with mutations in the Gαo-encoding gene. To address this gap, we sought to uncover novel Gαo effectors using a proximity-based proteomics screen in differentiated PC12 cells. Our analysis revealed a diverse set of potential Gαo-GTP effector proteins including a Rap1 GTPase activating protein, Rap1GAP1. Regulation of Rap1GAP1 by G protein α subunits is controversial, with Rap1GAP1 reported to bind preferentially to Gαo-GDP via a GoLoco/G protein regulatory (GPR) motif. We establish that Gαo-GTP binds and regulates Rap1GAP1 activity and reveal a novel mechanism for Gα subunit recognition by Rap1GAP1 where the presence or absence of key contact residues in the GoLoco/GPR motif confer differential recognition of Gαo guanine nucleotide binding status. We also show that pathologic GNAO1 mutations disrupt this functional relationship by preventing the activated Gα subunit from attaining a conformation required for effector binding. These data resolve controversies in the literature regarding activation-dependent binding and regulation of Rap1GAP by Gαo and help establish Rap1GAP1a as a bone fide G protein regulated effector. Furthermore, our study finds that multiple mutants in Gαo associated with GNAO1 encephalopathy have defects in downstream effector interactions, which could underly some of the manifestations of this disease.
期刊介绍:
The Journal of Biological Chemistry welcomes high-quality science that seeks to elucidate the molecular and cellular basis of biological processes. Papers published in JBC can therefore fall under the umbrellas of not only biological chemistry, chemical biology, or biochemistry, but also allied disciplines such as biophysics, systems biology, RNA biology, immunology, microbiology, neurobiology, epigenetics, computational biology, ’omics, and many more. The outcome of our focus on papers that contribute novel and important mechanistic insights, rather than on a particular topic area, is that JBC is truly a melting pot for scientists across disciplines. In addition, JBC welcomes papers that describe methods that will help scientists push their biochemical inquiries forward and resources that will be of use to the research community.